About this product
The tablet supplies 600 mg of Monascus purpureus red yeast rice in an extended-release format. Species identification and controlled release distinguish it from a basic powder capsule.
Active monacolin content is not stated, so potency remains unknown. No citrinin testing is supplied, which leaves contaminant control uncertain.
One tablet daily is convenient, but the serving cost is relatively high for the modest amount. The formula also lacks CoQ10 or another supporting ingredient.
Pros
Extended-release format Monascus purpureus identified Convenient one-tablet serving
Cons
No monacolin standardization No citrinin testing supplied High cost for a modest amount
Warnings
Red yeast rice may cause statin-like muscle or liver effects Do not combine casually with statin medicines Avoid red yeast rice during pregnancy or breastfeeding
